FDA Considers Updating COVID-19 Vaccines

The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee meets from 8:30 a.m. to 5:00 p.m. ET on June 15 to discuss the “selection of a specific XBB lineage (e.g., XBB.1.5 or XBB.1.16 or XBB.2.3) for inclusion in the 2023-2024 Formula of COVID-19 vaccines in the United States.”